Parkinson's Disease clinical trials in Alabama
18 active Parkinson's Disease trials with a site in Alabama. Describe your situation to see which ones look like a fit.
- A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Low Voltage Electrical Stimulation for Depression in Parkinson's Patients
- A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders
- A Study of Buntanetap in Participants With PD
- Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD
- Investigating Inhibitory Control Networks in Parkinson's Disease
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)
- The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
- Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
- Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease
- Parkinson's Foundation PD GENEration Genetic Registry
- PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease
- Passive Versus Active Music Therapy Parkinson's Disease
- Investigating the Increased Risk of Falls in Individuals With Parkinson's Disease Treated With Deep Brain Stimulation
- Study in Parkinson Disease of Exercise
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.